Is Complete Genomics, Inc. (GNOM) Going to Reward These Hedge Funds?

Page 1 of 2

Complete Genomics, Inc. (NASDAQ:GNOM)Complete Genomics, Inc. (NASDAQ:GNOM) was in 9 hedge funds’ portfolio at the end of the fourth quarter of 2012. GNOM investors should pay attention to an increase in activity from the world’s largest hedge funds lately. There were 7 hedge funds in our database with GNOM positions at the end of the previous quarter.

In the financial world, there are many metrics market participants can use to analyze their holdings. A couple of the most useful are hedge fund and insider trading movement. At Insider Monkey, our research analyses have shown that, historically, those who follow the best picks of the best investment managers can trounce the S&P 500 by a superb margin (see just how much).

Equally as integral, positive insider trading sentiment is another way to break down the world of equities. Obviously, there are a variety of stimuli for an insider to sell shares of his or her company, but just one, very simple reason why they would behave bullishly. Various academic studies have demonstrated the valuable potential of this tactic if investors know what to do (learn more here).

Now, it’s important to take a gander at the latest action surrounding Complete Genomics, Inc. (NASDAQ:GNOM).

How have hedgies been trading Complete Genomics, Inc. (NASDAQ:GNOM)?

At the end of the fourth quarter, a total of 9 of the hedge funds we track were long in this stock, a change of 29% from the third quarter. With hedge funds’ positions undergoing their usual ebb and flow, there exists a few notable hedge fund managers who were increasing their stakes significantly.

When looking at the hedgies we track, Cliff Asness’s AQR Capital Management had the most valuable position in Complete Genomics, Inc. (NASDAQ:GNOM), worth close to $7.7 million, accounting for less than 0.1%% of its total 13F portfolio. Coming in second is Carl Tiedemann and Michael Tiedemann of TIG Advisors, with a $3.8 million position; 0.7% of its 13F portfolio is allocated to the company. Some other peers with similar optimism include Jean-Marie Eveillard’s First Eagle Investment Management, James Dondero’s Highland Capital Management and Kerr Neilson’s Platinum Asset Management.

As aggregate interest increased, some big names have jumped into Complete Genomics, Inc. (NASDAQ:GNOM) headfirst. TIG Advisors, managed by Carl Tiedemann and Michael Tiedemann, initiated the most outsized position in Complete Genomics, Inc. (NASDAQ:GNOM). TIG Advisors had 3.8 million invested in the company at the end of the quarter. Jean-Marie Eveillard’s First Eagle Investment Management also made a $3.6 million investment in the stock during the quarter. The following funds were also among the new GNOM investors: Israel Englander’s Millennium Management, Jacob Gottlieb’s Visium Asset Management, and D. E. Shaw’s D E Shaw.

Insider trading activity in Complete Genomics, Inc. (NASDAQ:GNOM)

Bullish insider trading is most useful when the primary stock in question has seen transactions within the past half-year. Over the latest half-year time period, Complete Genomics, Inc. (NASDAQ:GNOM) has seen zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

Let’s also examine hedge fund and insider activity in other stocks similar to Complete Genomics, Inc. (NASDAQ:GNOM). These stocks are Vanda Pharmaceuticals Inc. (NASDAQ:VNDA), Omeros Corporation (NASDAQ:OMER), Inovio Pharmaceuticals Inc (NYSEAMEX:INO), and BioSpecifics Technologies Corp. (NASDAQ:BSTC). This group of stocks are the members of the biotechnology industry and their market caps resemble GNOM’s market cap.

Page 1 of 2
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

The 10 Most Peaceful Countries in the World

5 Big Reasons Communism Failed

The 15 Most Famous Carl Icahn Quotes

10 Scary Animals that are Actually Harmless

The 8 Most Famous Singer-Actors in Entertainment

The 10 Longest Wars of All Time

The 13 Worst Looking Foods that Taste Great

The 6 Most Gruesome Injuries Suffered During a Sports Match

The 20 Biggest Contracts in MLB History

The 7 Worst Blown Calls in Sports History

7 Free Ways to Advertise Your Business Online

The 18 Best R&B Songs of the 90’s

The 10 Most Dangerous States to be a Cop

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!